Home › Dermatomyositis › Pennsylvania
Dermatomyositis clinical trials in Pennsylvania
7 studies for Dermatomyositis are looking for participants at sites in Pennsylvania.
Cities in Pennsylvania
A Study to Investigate the Efficacy and Safety of Anifrolumab Administered as Subcutaneous Injection and Added to Standard of Care Compared With Placebo Added to Standard of Care in Adult Participants With Idiopathic Inflammatory Myopathies (Polymyositis and Dermatomyositis)
- Research Site, Philadelphia
- Research Site, Pittsburgh
RecruitingPhase 3
Ages 18 to 75 · All sexes · Updated Sep 24, 2026 · NCT06455449Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- UPMC Hillman Cancer Center, Pittsburgh
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT03816345RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
- Children's Hospital of Philadelphia - Accepting Young Adult and Juvenile Patients, Philadelphia
- UPMC Children's Hospital of Pittsburgh - Accepting Juvenile Patients, Pittsburgh
- UPMC Arthritis and Autoimmunity Center - Accepting Adult Patients, Pittsburgh
RecruitingPhase 2/3
Ages 6 to 75 · All sexes · Updated Sep 17, 2026 · NCT06154252A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]
- UPMC Arthritis and Autoimmunity Center, Falk Clinic, Pittsburgh
- UPMC Montefiore Clinical and Translational Research Center (CTRC), Pittsburgh
- UPMC Presbyterian Shadyside Hospital, Pittsburgh
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 15, 2026 · NCT05895786Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)
- University of Pennsylvania, Perelman Center for Advanced Medicine, Philadelphia
RecruitingPhase 1
Ages 18 to 85 · All sexes · Updated Jul 22, 2026 · NCT06371417Intralesional Injection of STS in Treatment of Calcinosis
- UPMC Arthritis and Autoimmunity Center, Pittsburgh
RecruitingPhase 2
Ages 18 and older · All sexes · Updated May 5, 2026 · NCT06672822Clinical Responsiveness of Dermatomyositis Using Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI)
- Hospital of the University of Pennsylvania, Philadelphia
RecruitingObservational study
Ages 18 and older · All sexes · Updated Mar 30, 2026 · NCT02945345From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.